Treatment Regimen Based On Dolutegravir Suppresses HIV To Undetectable Levels Better Than Therapy Based On Efavirenz, Study Indicates.

MedPage Today (7/24, Susman) reports that “a real-world study that included more than 100,000 people living with HIV infection appears to confirm that a treatment regimen based on the integrase inhibitor dolutegravir (Ticivay) suppresses the virus to und...